Submission declined on 14 May 2024 by Grabup (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
- Dr. Robert Sutherland Laidlaw
- Dr. Robert Sutherland Laidlaw** (born September 6, 1985, in Goondiwindi, Australia) is an Australian physician, notable for his contributions to healthcare data security and privacy, particularly within the subdomain of compliance and regulation in the cosmetic medicine industry.
- Early Life and Education
Dr. Laidlaw was raised in Donald, a rural area in north-western Victoria, Australia. He showed early academic promise, securing the role of school captain at Donald Primary School. At the age of 14, he left home to attend Ballarat Grammar School on a top-level academic scholarship. During his secondary education, Dr. Laidlaw participated in a cultural exchange program to Dijon, France, where he became fluent in French.
In 2010, Dr. Laidlaw completed his Bachelor of Medicine/Bachelor of Surgery at James Cook University. He passed the Generic Surgical Sciences Examination conducted by the Royal Australian College of Surgeons in 2018.
- Career
Dr. Laidlaw has been actively involved in various advisory roles. Notably, from 2009 to 2010, he served as a board member for the Queensland AIDS Council. His career features significant contributions to the field of health data, with a focus on the use of blockchain technology for ensuring data privacy and security.
- Publications and Research
Dr. Laidlaw has several notable publications: - "*Healthcare 2019: The year of the Big Data Blockchain*" (*Journal of Health Information Management, 2019*) - "*The future of secure health data is here and it’s called blockchain*" (*Proceedings of the HIMAA/NCCH 35th National ConferenceHealth Information Management: Engaging the Next Generation, 2018*, ISSN: 978-0 -9946206-5-1) - "*Repeated cannulation of umbilical hernia with Ventriculoperiotoneal shunt catheter*" (*Journal of Surgical Case Reports, 2014*, DOI: 10.1093/jscr/rju059) - "*Tumor-to-tumor Metastasis in the Spine*" (*The Journal of Spinal Surgery, 2014*, DOI: 10.5005/jp-journals-10039-1018)
- Notability
Dr. Laidlaw's work and expertise have been recognized in various media outlets, including a recent interview with Channel 9 news discussing AHPRA regulations for the cosmetic injectable industry.
- Personal Life
Dr. Laidlaw has never married and does not have children. Fluent in French, he often engages in discussing and promoting cross-cultural medical practices and education.
- External Links
- [LinkedIn](https://www.linkedin.com/in/robert-laidlaw) - Official website: [robertlaidlaw.com.au](https://robertlaidlaw.com.au)
Through his research, publications, and expert commentary, Dr. Laidlaw has established himself as a well-respected figure in both medical and academic communities, particularly in topics related to healthcare technology innovation and regulation.